EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways

Chandani Shrestha, Eun Hee Yoo, Barsha Deshar, Min Hwang, Shinwon Kang, Bum-Ho Bin, Ji Hyun Lee, Jiyoon Kim

BMB Reports · 31.08.2025 · 58 (8) · 357-363

DOI: 10.5483/bmbrep.2024-0115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMB Reports, online erschienen am 13.06.2025. Verfasst von Chandani Shrestha und 7 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Shrestha, C., Yoo, E. H., Deshar, B., Hwang, M., Kang, S., Bin, B., Lee, J. H., & Kim, J. (2025). Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways. BMB Reports, 58(8), 357-363. https://doi.org/10.5483/bmbrep.2024-0115

Vancouver

Shrestha C, Yoo EH, Deshar B, Hwang M, Kang S, Bin B, et al. Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways. BMB Reports. 2025;58(8):357-363. doi:10.5483/bmbrep.2024-0115

BibTeX
@article{Shrestha2025,
  author = {Shrestha, Chandani and Yoo, Eun Hee and Deshar, Barsha and Hwang, Min and Kang, Shinwon and Bin, Bum-Ho and Lee, Ji Hyun and Kim, Jiyoon},
  title = {Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways},
  journal = {BMB Reports},
  year = {2025},
  volume = {58},
  number = {8},
  pages = {357--363},
  doi = {10.5483/bmbrep.2024-0115}
}
Kostenlos starten →